PharmExec's 2010 Forecast Reflected in Thought Leader Select's Current Projects

While 2010 continues to be a challenging year for the pharmaceutical industry as a whole, certain targeted areas of development continue to gain attention from the industry.

In PharmExec’s 2010 forecast,Alexandra Kibble predicted continued focus on the following therapeutic areas:  cardiovascular, oncology, and anti-infectives.  Kibble also predicted a rise in pipeline development of treatments for central nervous system disorders and diabetes.

At Thought Leader Select, we are addressing impending client needs to work with key opinion leaders in endocrinology, cardiology, and neurology to meet the increasing demands for new drug therapies in these key areas.  Our work matches physician key opinion leaders, as well as non-traditional KOLs, such as nurse practitioners, physician assistants, and nurses, with pharma companies for critical development work on investigator teams, advisory boards, and other areas of deployment.

Read the entire PharmExec forecast here.

More Posts

The MSL Playbook for Creating Value

By Mark Schoeman, General Manager Prior to and over the course of the pandemic, assessments have shown that scores for MSL teams have remained consistent.


Send Us A Message